Market Value525,115,000
Total Holdings52
File Date2020-04-09
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
QQQ / Invesco QQQ Trust, Series 1 Put
SRPT / Sarepta Therapeutics, Inc.
AVRO / AVROBIO, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
MIST / Milestone Pharmaceuticals Inc.
ADVM / Adverum Biotechnologies, Inc.
CHRS / Coherus Oncology, Inc.
FXB / Invesco CurrencyShares British Pound Sterling Trust
SPY / SPDR S&P 500 ETF Put
SRPT / Sarepta Therapeutics, Inc. Put
AERI / Aerie Pharmaceuticals Inc
RCKT / Rocket Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc. Put
APLS / Apellis Pharmaceuticals, Inc. Call
MRTX / Mirati Therapeutics, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
FATE / Fate Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
ATNX / Athenex Inc
IOVA / Iovance Biotherapeutics, Inc.
SELB / Selecta Biosciences Inc
PHAS / PhaseBio Pharmaceuticals Inc
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
US60877T1007 / Momenta Pharmaceuticals, Inc.
EPZM / Epizyme Inc
TPTX / Turning Point Therapeutics Inc
/ Immunomedics, Inc. Call
/ Immunomedics, Inc.
KPTI / Karyopharm Therapeutics Inc.
US16706W1027 / Chiasma Inc
SPPI / Spectrum Pharmaceuticals, Inc.
PCRX / Pacira BioSciences, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ANAB / AnaptysBio, Inc.
FXF / Invesco CurrencyShares Swiss Franc Trust
DRNA / Dicerna Pharmaceuticals Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call
FIXX / Homology Medicines, Inc.
DERM / Journey Medical Corporation
GBT / Global Blood Therapeutics Inc.
ARQL / ArQule, Inc.
MRSN / Mersana Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
MYOV / Myovant Sciences Ltd
AUPH / Aurinia Pharmaceuticals Inc.
SLDB / Solid Biosciences Inc.
FOLD / Amicus Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
SAGE / Sage Therapeutics, Inc. Call
SAGE / Sage Therapeutics, Inc.
ISEE / IVERIC bio Inc
IOVA / Iovance Biotherapeutics, Inc. Call
ARGX / argenx SE - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd.
VRAY / ViewRay Inc.
CBAY / CymaBay Therapeutics, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
ARVN / Arvinas, Inc.
TGTX / TG Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
BPMC / Blueprint Medicines Corporation
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
AXSM / Axsome Therapeutics, Inc.